Uwe Klein

1.2k total citations
18 papers, 1.0k citations indexed

About

Uwe Klein is a scholar working on Molecular Biology, Social Psychology and Organic Chemistry. According to data from OpenAlex, Uwe Klein has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Social Psychology and 3 papers in Organic Chemistry. Recurrent topics in Uwe Klein's work include Receptor Mechanisms and Signaling (9 papers), Neuroendocrine regulation and behavior (5 papers) and Renin-Angiotensin System Studies (3 papers). Uwe Klein is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neuroendocrine regulation and behavior (5 papers) and Renin-Angiotensin System Studies (3 papers). Uwe Klein collaborates with scholars based in United States, Germany and Switzerland. Uwe Klein's co-authors include Falk Fahrenholz, Gerald Gimpl, Theodore W. Kurtz, Mark von Zastrow, M. Teresa Ramirez, Brian K. Kobilka, Jacqueline A.M. Smith, Mathai Mammen, Adam D. Hughes and Tod Steinfeld and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Biochemistry.

In The Last Decade

Uwe Klein

18 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uwe Klein United States 12 625 190 157 127 127 18 1.0k
T D Chrisman United States 18 735 1.2× 120 0.6× 109 0.7× 209 1.6× 201 1.6× 22 1.2k
Akiko Watabe Japan 14 838 1.3× 293 1.5× 101 0.6× 92 0.7× 331 2.6× 29 1.7k
Sharad Mistry United Kingdom 17 723 1.2× 240 1.3× 149 0.9× 51 0.4× 181 1.4× 34 1.2k
M L Toews United States 22 942 1.5× 327 1.7× 151 1.0× 34 0.3× 234 1.8× 34 1.3k
Megumi Tsuchiya Japan 20 511 0.8× 293 1.5× 49 0.3× 38 0.3× 145 1.1× 49 987
Cheryl Lyons United States 7 327 0.5× 105 0.6× 139 0.9× 129 1.0× 609 4.8× 12 1.2k
Douglas R. Brandt United States 10 685 1.1× 289 1.5× 124 0.8× 68 0.5× 74 0.6× 15 914
Jacques Winand Belgium 18 588 0.9× 400 2.1× 50 0.3× 75 0.6× 149 1.2× 67 925
Elizabeth Donohue Canada 14 687 1.1× 241 1.3× 178 1.1× 22 0.2× 69 0.5× 14 1.3k
K Gietzen Germany 14 639 1.0× 162 0.9× 81 0.5× 92 0.7× 143 1.1× 28 887

Countries citing papers authored by Uwe Klein

Since Specialization
Citations

This map shows the geographic impact of Uwe Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Klein more than expected).

Fields of papers citing papers by Uwe Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Klein. The network helps show where Uwe Klein may publish in the future.

Co-authorship network of co-authors of Uwe Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Klein. A scholar is included among the top collaborators of Uwe Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Klein. Uwe Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Choi, Seok Ki, Joe Budman, Craig Hill, et al.. (2018). Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI). ACS Medicinal Chemistry Letters. 10(1). 86–91. 11 indexed citations
2.
Bourdet, David L., Craig Hill, Kevin DeMent, et al.. (2015). Abstract 19056: Discovery of Potent and Selective Neprilysin Inhibitors Exhibiting Sustained Pharmacodynamic Activity and Non-renal Elimination in Rats. Circulation. 132(suppl_3). 1 indexed citations
3.
Klein, Uwe, Martin S. Linsell, Edmund J. Moran, et al.. (2014). Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD. Bioorganic & Medicinal Chemistry Letters. 24(13). 2871–2876. 10 indexed citations
4.
Jacobsen, John R., James B. Aggen, Uwe Klein, et al.. (2014). Multivalent design of long-acting β2-adrenoceptor agonists incorporating biarylamines. Bioorganic & Medicinal Chemistry Letters. 24(12). 2625–2630. 7 indexed citations
5.
Jacobsen, John R., Seok Ki Choi, Uwe Klein, et al.. (2011). A multivalent approach to the discovery of long-acting β2-adrenoceptor agonists for the treatment of asthma and COPD. Bioorganic & Medicinal Chemistry Letters. 22(2). 1213–1218. 25 indexed citations
6.
Hegde, Laxminarayan G., Craig Hill, Kevin DeMent, et al.. (2011). Comparative efficacy of AHU-377, a potent neprilysin inhibitor, in two rat models of volume-dependent hypertension. BMC Pharmacology. 11(S1). 5 indexed citations
7.
Hegde, Laxminarayan G., Harold Thibodeaux, Scott R. Armstrong, et al.. (2011). Concomitant Angiotensin AT1 Receptor Antagonism and Neprilysin Inhibition Produces Omapatrilat-like Antihypertensive Effects Without Promoting Tracheal Plasma Extravasation in the Rat. Journal of Cardiovascular Pharmacology. 57(4). 495–504. 52 indexed citations
8.
Steinfeld, Tod, Adam D. Hughes, Uwe Klein, Jacqueline A.M. Smith, & Mathai Mammen. (2010). THRX-198321 Is a Bifunctional Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist (MABA) That Binds in a Bimodal and Multivalent Manner. Molecular Pharmacology. 79(3). 389–399. 36 indexed citations
9.
Kurtz, Theodore W. & Uwe Klein. (2009). Next generation multifunctional angiotensin receptor blockers. Hypertension Research. 32(10). 826–834. 62 indexed citations
10.
11.
McCluskie, Kerryn, et al.. (2006). Phosphodiesterase Type 4 Inhibitors Cause Proinflammatory Effects in Vivo. Journal of Pharmacology and Experimental Therapeutics. 319(1). 468–476. 27 indexed citations
12.
Klein, Uwe, Claudia Müller, Peter C. Chu, Mariel Birnbaumer, & Mark von Zastrow. (2001). Heterologous Inhibition of G Protein-coupled Receptor Endocytosis Mediated by Receptor-specific Trafficking of β-Arrestins. Journal of Biological Chemistry. 276(20). 17442–17447. 32 indexed citations
13.
Klein, Uwe, M. Teresa Ramirez, Brian K. Kobilka, & Mark von Zastrow. (1997). A Novel Interaction between Adrenergic Receptors and the α-Subunit of Eukaryotic Initiation Factor 2B. Journal of Biological Chemistry. 272(31). 19099–19102. 64 indexed citations
14.
Fahrenholz, Falk, Uwe Klein, & Gerald Gimpl. (1996). Conversion of the myometrial oxytocin receptor from low to high affinity state by cholesterol. MPG.PuRe (Max Planck Society). 311–319. 7 indexed citations
15.
16.
Klein, Uwe, Gerald Gimpl, & Falk Fahrenholz. (1995). Alteration of the Myometrial Plasma Membrane Cholesterol Content with .beta.-Cyclodextrin Modulates the Binding Affinity of the Oxytocin Receptor. Biochemistry. 34(42). 13784–13793. 477 indexed citations
17.
Pávó, Imre, et al.. (1994). Enhanced selectivity of oxytocin antagonists containing sarcosine in position 7. Journal of Medicinal Chemistry. 37(2). 255–259. 9 indexed citations
18.
Klein, Uwe & Falk Fahrenholz. (1994). Reconstitution of the myometrial oxytocin receptor into proteoliposomes. European Journal of Biochemistry. 220(2). 559–567. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T D Chrisman Breakdown of academic impact, for papers by Akiko Watabe Breakdown of academic impact, for papers by Sharad Mistry Breakdown of academic impact, for papers by M L Toews Breakdown of academic impact, for papers by Megumi Tsuchiya Breakdown of academic impact, for papers by Cheryl Lyons Breakdown of academic impact, for papers by Douglas R. Brandt Breakdown of academic impact, for papers by Jacques Winand Breakdown of academic impact, for papers by Elizabeth Donohue Breakdown of academic impact, for papers by K Gietzen
Rankless by CCL
2026